Immunotherapy for Head and Neck Cancer Treatment
1 Views
administrator
07/02/23
Head and neck cancer and skull base surgeon Nyall London discusses immunotherapy clinical trials that have contributed to FDA approval for nivolumab and pembrolizumab for recurrent head and neck squamous cell carcinoma. https://hopkinsmedicine.org/oto #HeadandNeckCancerTreatment #JohnsHopkins
-
Category
Show more
Facebook Comments
No comments found